Alliance A061202: ixazomib, pomalidomide, and dexamethasone for patients with lenalidomide-refractory MM in first relapse
- Citation:
- Blood Adv vol 8 (19) 5039-50
- Year:
- 2024
- Type:
- Manuscript
- Funding:
- NCTN
- Endpoint:
- Primary
- Analysis:
- Primary
- Data Sharing:
- No-Data-Sharing
- Status:
- Presented/Published
- Citation Status:
- ppub
- Note:
- Methodological:
- No
- Biospecimen:
- No
- SDC:
- No
- Book Volume:
- 14
- Parents:
- 3794
- Children:
- None
- Pharmas:
- Celgene/BMS, Takeda Oncology
- Grants:
- U10CA180821, U10CA180882, UG1CA233180, UG1CA233191, UG1CA233290, UG1CA233331, UG1CA233373
- Corr. Author:
- Authors:
- Peter Voorhees Vera Suman Yvonne Efebera Noopur Raje Sascha Tuchman Cesar Rodriguez Jacob Laubach Misty Bova-Solem Destin Carlisle Saad Usmani Philip McCarthy Paul G. Richardson
- Networks:
- LAPS-MA036, LAPS-MN026, LAPS-NC007, LAPS-NY016, LAPS-NY158, NC002, OH008
- Study
- Alliance-A061202
- Multiple Studies, or Legacy Studies in Alliance Study:
- Phases:
- 1/2
- Keywords: